This clinical trial evaluates whether the Transportation for Cancer Care Navigation Tool (TRACT) can reduce travel barriers among patients with solid tumors receiving radiation therapy. It is estimated that 20-30% patients with cancer experience travel-related barriers for cancer care. This is a particular problem for patients with radiation therapy as these patients frequently receive multiple treatment cycles, which often require daily treatment for multiple weeks or months. Addressing travel barriers has been a prerequisite for cancer care as travel barriers negatively influence cancer treatment adherence and cancer care outcomes, such as survival and quality of life. The TRACT program may help reduce travel barriers and therefore promote health equity among patients with solid tumors receiving radiation therapy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility of screening patients for the Transportation for Cancer Care Navigation Tool (TRACT) program
Timeframe: At T0 (pre-intervention) and T1 (3 months post-intervention)
Recruitment to the TRACT program (Feasibility)
Timeframe: At T0 (pre-intervention) and T1 (3 months post-intervention)
Retention and adherence rate (Feasibility)
Timeframe: At T0 (pre-intervention) and T1 (3 months post-intervention)
Acceptability of the Transportation for Cancer Care Navigation Tool
Timeframe: At T0 (pre-intervention) and T1 (3 months post-intervention)
Travel barriers
Timeframe: At T0 (3 months) and T1 (3 months post-intervention)
Treatment adherence
Timeframe: At T1 (3 months post-intervention)
Distress
Timeframe: At T0 (3 months) and T1 (3 months post-intervention)
Financial toxicity
Timeframe: At T0 (3 months) and T1 (3 months post-intervention)
Quality of life (QOL)
Timeframe: At T0 (3 months) and T1 (3 months post-intervention)